Enhanced virulence and neuroinvasion of contemporary Oropouche virus strains in the AG129 mouse model.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nobre Santos Ellen Caroline, Costa Silva Nathália, Godoy Rodrigues Pinto Luiza, Pontes Santos Luiz Gustavo, da Silva Brandi Oliveira Juliana, Teixeira Goulart Melissa, Neves Rocha Marcele, de Faria Isaque João da Silva, de Souza Renan Pedra, de Mendonça Silvana F, Baldon Livia, Todjiro Yaovi M H, de Freitas Amanda C, Moreira Rafaela L, Rodrigues Maria E C, Amadou Siad, Fernandes José M G, Guimarães Natália R, Adelino Talita E R, Dos Santos Sara C F, Iani Felipe C M, Moreno Keldenn M F, de Almeida João P P, Alcantara Luiz, Giovanetti Marta, Ribeiro Fabíola Mara, Ferreira Álvaro G A
Аннотация
Oropouche virus (OROV) is an orthobunyavirus undergoing dramatic re-emergence and rapid geographic expansion across Central and South America, coinciding with the emergence of reassortant lineages carrying novel segment combinations and adaptive mutations. Despite extensive genomic and epidemiological characterization, the biological mechanisms driving OROV resurgence during 2023-2024 remain unclear. Here, we show that contemporary reassortant OROV isolates exhibit markedly enhanced virulence in the AG129 mouse model compared with the historical prototype strain OROVBeAn19991. Two reassortant 2024 isolates-OROVSC2024 from a non-Amazonian region and OROVAC2024 from the Amazon Basin-produced significantly higher viremia, accelerated disease progression, and increased mortality. These isolates disseminated widely, generating substantially elevated viral loads across multiple organs, including the spleen, kidney, liver, lung, uterus, and testes, and-most notably-demonstrated a heightened capacity for the brain. Infection with contemporary reassortant lineages also induced pro-inflammatory responses, characterized by consistent upregulation of IL-1β across tissues. Together, these findings provide experimental evidence that ongoing viral evolution is likely driving a measurable increase in OROV pathogenicity, providing a biological framework to better understand the increased severity of clinical cases reported in recent outbreaks. This work underscores the urgent need for enhanced surveillance, real-time genomic monitoring, and development of targeted countermeasures against this rapidly spreading arbovirus.